Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel A Rubio Herrera

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Endocrinologia, Diabetes Y Nutricion|February 7, 2025
Controversies on the effects of GLP-1 receptor agonist treatment on gastric emptyingMiguel A Rubio-Herrera, Irene Bretón Lesmes
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|February 4, 2014
[Pharmacological treatment of obesity]Miguel A Rubio-Herrera, Carmen Moreno-Lopera
Medicina Clinica|August 27, 2025
Weight management treatment in obesityMiguel A Rubio-Herrera, Sara Mera-Carreiro
Endocrinologia, Diabetes Y Nutricion|November 9, 2020
Obesity in the COVID era: A global health challengeMiguel A Rubio Herrera, Irene Bretón Lesmes
Endocrinologia, Diabetes Y Nutricion|April 15, 2024
[Obesity in the COVID era: A global health challenge]Miguel A Rubio Herrera, Irene Bretón Lesmes
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|August 6, 2013
Metabolic surgery: quo vadis?Ana M Ramos-Leví, Miguel A Rubio Herrera
Nutricion Hospitalaria|July 30, 2013
Dermatitis and optic neuropathy due to zinc deficiency after malabsortive bariatric surgeryAna M Ramos-Leví, Andrés Sánchez-Pernaute, Miguel A Rubio Herrera
Nutricion Hospitalaria|September 10, 2013
Update on pharmacology of obesity: benefits and risksLucio Cabrerizo García, Ana Ramos-Leví, Carmen Moreno Lopera, et al.
Biomedicines|October 28, 2023
Impact of Treatment with GLP1 Receptor Agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, While on a Waiting List for Bariatric SurgeryMiguel A Rubio-Herrera, Sara Mera-Carreiro, Andrés Sánchez-Pernaute, et al.
Nutricion Hospitalaria|July 30, 2013
Bariatric surgery in type 1 diabetes mellitus; long-term experience in two casesNuria Fuertes-Zamorano, Andrés Sánchez-Pernaute, Antonio J Torres García, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Endocrinologia, Diabetes Y Nutricion|February 7, 2025
Controversies on the effects of GLP-1 receptor agonist treatment on gastric emptyingMiguel A Rubio-Herrera, Irene Bretón Lesmes
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|February 4, 2014
[Pharmacological treatment of obesity]Miguel A Rubio-Herrera, Carmen Moreno-Lopera
Medicina Clinica|August 27, 2025
Weight management treatment in obesityMiguel A Rubio-Herrera, Sara Mera-Carreiro
Endocrinologia, Diabetes Y Nutricion|November 9, 2020
Obesity in the COVID era: A global health challengeMiguel A Rubio Herrera, Irene Bretón Lesmes
Endocrinologia, Diabetes Y Nutricion|April 15, 2024
[Obesity in the COVID era: A global health challenge]Miguel A Rubio Herrera, Irene Bretón Lesmes
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|August 6, 2013
Metabolic surgery: quo vadis?Ana M Ramos-Leví, Miguel A Rubio Herrera
Nutricion Hospitalaria|July 30, 2013
Dermatitis and optic neuropathy due to zinc deficiency after malabsortive bariatric surgeryAna M Ramos-Leví, Andrés Sánchez-Pernaute, Miguel A Rubio Herrera
Nutricion Hospitalaria|September 10, 2013
Update on pharmacology of obesity: benefits and risksLucio Cabrerizo García, Ana Ramos-Leví, Carmen Moreno Lopera, et al.
Biomedicines|October 28, 2023
Impact of Treatment with GLP1 Receptor Agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, While on a Waiting List for Bariatric SurgeryMiguel A Rubio-Herrera, Sara Mera-Carreiro, Andrés Sánchez-Pernaute, et al.
Nutricion Hospitalaria|July 30, 2013
Bariatric surgery in type 1 diabetes mellitus; long-term experience in two casesNuria Fuertes-Zamorano, Andrés Sánchez-Pernaute, Antonio J Torres García, et al.
Pageof 3